Department of Traditional Chinese Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Systems Biology & Bioinformatics Unit, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute, Jena, Germany.
Front Endocrinol (Lausanne). 2022 Nov 9;13:1063579. doi: 10.3389/fendo.2022.1063579. eCollection 2022.
Metabolic syndrome (MS) is a group of complex medical conditions that can lead to serious cardiovascular and cerebrovascular diseases. According to the theory of traditional Chinese medicine (TCM), MS can be divided into two main subtypes termed 'phlegm-dampness syndrome' (TSZE) and 'qi-yin deficiency syndrome' (QYLX). At present, the research into intestinal microbiota of different TCM syndromes of MS and its association with clinical manifestation is lacking.
Using 16S rRNA sequencing, we performed a cross-sectional analysis of human gut microbiota between two different TCM syndromes (QYLX and TSZE, n=60) of MS, and their differences with healthy participants (n=30).
We found that the QYLX and TSZE groups differ from the healthy control group in the overall gut microbiota composition, and some specific microbial taxa and functional pathways. Moreover, significantly differentially abundant taxa and distinct BMI-correlated taxa were observed between QYLX and TSZE groups, suggesting the potential contribution of gut microbiota to the distinction between the two TCM syndromes. The predicted functional profiles also showed considerable differences, especially pathways related to amino acid metabolism and lipopolysaccharide synthesis.
Our study highlights the gut microbiota's contribution to the differentiation between two TCM syndromes of MS and may provide the rationale for adopting different microbiota-directed treatment strategies for different TCM syndromes of MS in the future.
代谢综合征(MS)是一组复杂的医学病症,可能导致严重的心脑血管疾病。根据中医理论,MS 可分为“痰浊证”(TSZE)和“气阴两虚证”(QYLX)两种主要亚型。目前,关于不同 MS 中医证型的肠道微生物群及其与临床表现的关联的研究还比较缺乏。
我们采用 16S rRNA 测序技术,对 MS 的两种不同中医证型(QYLX 和 TSZE,n=60)与健康参与者(n=30)的肠道微生物群进行了横断面分析。
我们发现,QYLX 和 TSZE 组与健康对照组的肠道微生物群组成存在差异,一些特定的微生物类群和功能途径也存在差异。此外,QYLX 和 TSZE 组之间存在显著差异丰度的分类群和与 BMI 相关的独特分类群,提示肠道微生物群可能对两种中医证型的区分有潜在贡献。预测的功能谱也显示出明显的差异,特别是与氨基酸代谢和脂多糖合成相关的途径。
本研究强调了肠道微生物群对 MS 两种中医证型的区分作用,可能为未来针对不同中医证型的 MS 采用不同的基于微生物群的治疗策略提供依据。